Literature DB >> 23598389

When metabolism met immunology.

Marc Y Donath.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23598389     DOI： 10.1038/ni.2591

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  13 in total

Review 1.  Type 2 diabetes as an inflammatory disease.

Authors:  Marc Y Donath; Steven E Shoelson
Journal:  Nat Rev Immunol       Date:  2011-01-14       Impact factor: 53.106

2.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation.

Authors:  Rongbin Zhou; Aubry Tardivel; Bernard Thorens; Inpyo Choi; Jürg Tschopp
Journal:  Nat Immunol       Date:  2009-12-20       Impact factor: 25.606

3.  Gout-associated uric acid crystals activate the NALP3 inflammasome.

Authors:  Fabio Martinon; Virginie Pétrilli; Annick Mayor; Aubry Tardivel; Jürg Tschopp
Journal:  Nature       Date:  2006-01-11       Impact factor: 49.962

4.  Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling.

Authors:  Haitao Wen; Denis Gris; Yu Lei; Sushmita Jha; Lu Zhang; Max Tze-Han Huang; Willie June Brickey; Jenny P-Y Ting
Journal:  Nat Immunol       Date:  2011-04-10       Impact factor: 25.606

5.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Frédéric Ris; José Oberholzer; Helen I Joller-Jemelka; Giatgen A Spinas; Nurit Kaiser; Philippe A Halban; Marc Y Donath
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

6.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals.

Authors:  Peter Duewell; Hajime Kono; Katey J Rayner; Cherilyn M Sirois; Gregory Vladimer; Franz G Bauernfeind; George S Abela; Luigi Franchi; Gabriel Nuñez; Max Schnurr; Terje Espevik; Egil Lien; Katherine A Fitzgerald; Kenneth L Rock; Kathryn J Moore; Samuel D Wright; Veit Hornung; Eicke Latz
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

7.  Elevation of C-reactive protein in "active" coronary artery disease.

Authors:  B C Berk; W S Weintraub; R W Alexander
Journal:  Am J Cardiol       Date:  1990-01-15       Impact factor: 2.778

Review 8.  Mammalian sirtuins: biological insights and disease relevance.

Authors:  Marcia C Haigis; David A Sinclair
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

9.  Identification of a SIRT1 mutation in a family with type 1 diabetes.

Authors:  Anna Biason-Lauber; Marianne Böni-Schnetzler; Basil P Hubbard; Karim Bouzakri; Andrea Brunner; Claudia Cavelti-Weder; Cornelia Keller; Monika Meyer-Böni; Daniel T Meier; Caroline Brorsson; Katharina Timper; Gil Leibowitz; Andrea Patrignani; Remy Bruggmann; Gino Boily; Henryk Zulewski; Andreas Geier; Jennifer M Cermak; Peter Elliott; James L Ellis; Christoph Westphal; Urs Knobel; Jyrki J Eloranta; Julie Kerr-Conte; François Pattou; Daniel Konrad; Christian M Matter; Adriano Fontana; Gerhard Rogler; Ralph Schlapbach; Camille Regairaz; José M Carballido; Benjamin Glaser; Michael W McBurney; Flemming Pociot; David A Sinclair; Marc Y Donath
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

10.  The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance.

Authors:  Bolormaa Vandanmagsar; Yun-Hee Youm; Anthony Ravussin; Jose E Galgani; Krisztian Stadler; Randall L Mynatt; Eric Ravussin; Jacqueline M Stephens; Vishwa Deep Dixit
Journal:  Nat Med       Date:  2011-01-09       Impact factor: 53.440
View more
  8 in total

Review 1.  The Interconnection Between Immuno-Metabolism, Diabetes, and CKD.

Authors:  Fabrizia Bonacina; Andrea Baragetti; Alberico Luigi Catapano; Giuseppe Danilo Norata
Journal:  Curr Diab Rep       Date:  2019-03-19       Impact factor: 4.810

2.  An old molecule with a new role: microtubules in inflammasome regulation.

Authors:  Prasanna Tamarapu Parthasarathy; Young Cho; Richard Lockey; Narasaiah Kolliputi
Journal:  Cell Biochem Biophys       Date:  2014-09       Impact factor: 2.194

Review 3.  Targeting inflammation in the treatment of type 2 diabetes: time to start.

Authors:  Marc Y Donath
Journal:  Nat Rev Drug Discov       Date:  2014-05-23       Impact factor: 84.694

Review 4.  Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Authors:  S F Yanuck; J Pizzorno; H Messier; K N Fitzgerald
Journal:  Integr Med (Encinitas)       Date:  2020

Review 5.  Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease.

Authors:  Marc Y Donath; Daniel T Meier; Marianne Böni-Schnetzler
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

6.  Knockout of silent information regulator 2 (SIRT2) preserves neurological function after experimental stroke in mice.

Authors:  Lea Krey; Fred Lühder; Kathrin Kusch; Bozena Czech-Zechmeister; Birte Könnecke; Tiago Fleming Outeiro; George Trendelenburg
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-29       Impact factor: 6.200

Review 7.  Visceral Adipose Tissue: A New Target Organ in Virus-Induced Type 1 Diabetes.

Authors:  Danny Zipris
Journal:  Front Immunol       Date:  2021-08-04       Impact factor: 7.561

8.  Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.

Authors:  Emily Hams; Richard M Locksley; Andrew N J McKenzie; Padraic G Fallon
Journal:  J Immunol       Date:  2013-10-28       Impact factor: 5.422
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.